生物技术产业上市公司财务竞争力评价研究

发布时间：2018-01-22 10:20

本文关键词： 财务竞争力生物技术产业因子分析评价　出处：《东北农业大学》2014年硕士论文　论文类型：学位论文

【摘要】：财务竞争力是企业长期健康发展的保障,企业间的竞争,财务竞争力是重要的决定性因素,财务竞争力的强弱决定了企业能否长期生存和持续发展,因此,对财务竞争力强弱的评价就非常重要。生物技术产业是我国近年来的新兴产业,国家连年出台多项政策支持这一战略性产业的优先发展,生物技术产业中的企业需要高科技与创新,需要大量的资金支持研发与实践,普遍具有投入高、风险大的特点。所以,生物技术企业的财务问题研究是一项重要的课题,对行业中企业财务竞争力进行评价更应作为重中之重,上市公司是企业中的代表,因此,对生物技术产业上市公司财务竞争力的评价具有更深刻的理论和现实意义。通过综合运用系统分析法、主成分分析法与排序评价法相结合、比较分析法等研究方法,旨在借助上述方法分析出生物技术产业上市公司财务竞争力的主要影响因子,通过构建评价体系对其整体情况进行综合与分类评价,探讨由此提出该类企业财务竞争力提升的建议,为生物技术产业上市公司提高财务竞争力提供可靠的依据。全文由八部分组成,以财务战略理论、竞争优势理论、企业核心能力理论等理论为研究基础,通过生物技术产业上市公司财务竞争力的特点、构成要素与形成机制分析,选取有代表性的99家生物技术产业上市公司,结合因子分析模型,综合分析我国生物技术产业上市公司财务竞争力的状况,而后进行评价。研究表明生物技术产业上市公司财务竞争力的最主要影响因子为偿债能力因子。行业内上市公司财务竞争力水平普遍较低。样本公司综合得分大多在0附近。在生物技术产业企业四大分类中,化工生物技术类表现出了较强的财务竞争力,农业生物技术类企业表现出了最弱的财务竞争力,且只有农业生物技术类企业综合得分为负值,说明这一类企业是最需要提高其财务竞争力的。提升生物技术企业的财务竞争力要从各个影响能力方面整体优化,全面着手,不要顾此失彼。综上,结合实证研究结果,提出生物技术产业上市公司财务竞争力的提升建议,以提高生物技术产业上市公司财务竞争力,进而提高高科技行业整体竞争力和保持持续竞争优势,使企业持续、健康、稳定发展,保证企业的价值创造和战略目标的实现。
[Abstract]:Financial competitiveness is the guarantee of long-term healthy development of enterprises, competition among enterprises, financial competitiveness is an important decisive factor, the strength of financial competitiveness determines the long-term survival and sustainable development of enterprises. The evaluation of financial competitiveness is very important. Biotechnology industry is a new industry in China in recent years, the country has issued a number of policies to support the priority development of this strategic industry. Enterprises in biotechnology industry need high technology and innovation, need a lot of funds to support R & D and practice, generally have the characteristics of high investment and high risk. The research on the financial problems of biotechnology enterprises is an important subject. The evaluation of the financial competitiveness of the enterprises in the industry should be regarded as the most important. The listed companies are the representatives of the enterprises. The evaluation of financial competitiveness of listed companies in biotechnology industry has more profound theoretical and practical significance. Through the comprehensive use of system analysis, principal component analysis and ranking evaluation method combined, comparative analysis and other research methods. The purpose of this paper is to analyze the main influencing factors of the financial competitiveness of listed companies in biotechnology industry with the help of the above methods, and to evaluate the overall situation of the listed companies by constructing an evaluation system. This paper discusses the suggestions of improving the financial competitiveness of this kind of enterprises, and provides a reliable basis for the listed companies in biotechnology industry to improve their financial competitiveness. The full text consists of eight parts, based on the theory of financial strategy. Based on the theory of competitive advantage and the theory of core competence of enterprises, this paper analyzes the factors and forming mechanism of the financial competitiveness of listed companies in biotechnology industry. Select 99 representative biotechnology industry listed companies, combined with factor analysis model, comprehensive analysis of the status of financial competitiveness of Chinese biotechnology industry listed companies. The research shows that the main influencing factor of the financial competitiveness of the listed companies in biotechnology industry is the solvency factor. The level of financial competitiveness of listed companies in the industry is generally low. The comprehensive score of the sample companies is large. Most of them are near zero. In the four categories of biotechnology industry enterprises. Chemical biotechnology showed a strong financial competitiveness, agricultural biotechnology enterprises showed the weakest financial competitiveness, and only agricultural biotechnology enterprises had negative scores. This kind of enterprise is the most need to improve its financial competitiveness. To enhance the financial competitiveness of biotechnology enterprises from each aspect of the overall optimization of the ability to impact, and do not ignore one another. Based on the results of empirical research, this paper puts forward some suggestions on how to improve the financial competitiveness of listed companies in biotechnology industry in order to improve the financial competitiveness of listed companies in biotechnology industry. Furthermore, it can improve the overall competitiveness of the high-tech industry and maintain the sustainable competitive advantage so as to ensure the sustained, healthy and stable development of the enterprise, and ensure the value creation and the realization of the strategic goal of the enterprise.
【学位授予单位】：东北农业大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：F426.72;F406.7;F276.6

【参考文献】